Leukemia

Showing NaN - NaN of 315

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)

Active, not recruiting
  • Leukemia
  • Birmingham, Alabama
  • +184 more
Feb 4, 2022

Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 2, 2022

Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)

Recruiting
  • Lymphoma
  • +2 more
  • Kappa CD28 T cells
  • Houston, Texas
  • +1 more
Jan 31, 2022

Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,

Completed
  • Disorder Related to Bone Marrow Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 18, 2021

Development ofVideo Game for Improvement of Outcomes in Stem

Recruiting
  • Leukemia
  • Lymphoma
  • Focus Group
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 19, 2021

Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Nivolumab, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 9, 2021

Leukemia, Lymphoma Trial in Houston (other, behavioral, dietary supplement)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • Counseling
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 17, 2021

Leukemia Trial in Worldwide (BMS-936564, Cytarabine)

Terminated
  • Leukemia
  • Los Angeles, California
  • +37 more
Aug 18, 2021

Chronic Lymphocytic Leukemia, Leukemia Trial in Houston (Fludarabine, Cyclophosphamide, Rituximab)

Completed
  • Chronic Lymphocytic Leukemia
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 11, 2021

After Whole Brain Radiation Therapy for Hematologic Malignancies

Recruiting
  • Central Nervous System Lymphoma
  • +5 more
  • Magnetic Resonance Imaging
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 12, 2021

Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)

Active, not recruiting
  • Leukemia
  • Birmingham, Alabama
  • +175 more
Aug 16, 2021

B-Cell Non-Hodgkin Lymphoma, Hematopoietic and Lymphoid Cell Tumor, Leukemia Trial in Houston (Ipilimumab, Lenalidomide)

Active, not recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 6, 2021

Leukemia, CLL Trial in Houston (Lenalidomide)

Completed
  • Leukemia
  • CLL
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 30, 2021

Leukemia Trial in Canada, United States (troxacitabine)

Completed
  • Leukemia
  • Duarte, California
  • +19 more
Jun 7, 2021

Leukemia Trial in Houston (MEK 162)

Terminated
  • Leukemia
  • MEK 162
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 25, 2021

Leukemia Trial in Worldwide (asparaginase, cytarabine, daunorubicin HCl)

Completed
  • Leukemia
  • Birmingham, Alabama
  • +197 more
Mar 22, 2021

Leukemia, Lymphoma Trial in Houston (HSCT, DLI)

Completed
  • Leukemia
  • Lymphoma
  • HSCT
  • DLI
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 9, 2021

Stem Cell Transplantation, Leukemia Trial in Houston (Fludarabine, Busulfan, Thymoglobulin)

Completed
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 21, 2021

Myelodysplastic Syndrome, Leukemia, Acute Myeloid Leukemia Trial in Houston (Busulfan, Fludarabine)

Completed
  • Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 12, 2021

Leukemia, Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome Trial in Houston (drug, biological, other)

Recruiting
  • Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 13, 2021

Leukemia, Lymphoma Trial in Houston (drug, radiation, procedure)

Completed
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2021

Cognitive Training in Attenuating Attention Deficits/Child

Active, not recruiting
  • Leukemia
  • +2 more
  • Cognitive Training Program
  • Control Group
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 29, 2020

Leukemia, Lymphoma Trial in Houston (Actonel (Risedronate), Calcium, Vitamin D)

Completed
  • Leukemia
  • Lymphoma
  • Actonel (Risedronate)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 2, 2020

Leukemia Trial in Houston (Decitabine, Azacitidine)

Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 1, 2020